Active Matrix Metalloproteinases Are Present in Cartilage During Immune Complex-Mediated Arthritis: A Pivotal Role for Stromelysin-1 in Cartilage Destruction
Open Access
- 15 November 1999
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 163 (10) , 5633-5639
- https://doi.org/10.4049/jimmunol.163.10.5633
Abstract
The involvement of immune complexes during experimental arthritis in induction of metalloproteinases (MMP)-induced neoepitopes in aggrecan in cartilage, as well as the role of stromelysin-1 (SLN-1) in the induction of this neoepitope, was investigated. Passive immune complex arthritis was induced, and generation of the MMP-specific cleavage product (VDIPEN) was studied by immunolocalization. The role of SLN-1 was studied with use of SLN-1-deficient (SLN-1KO) mice. VDIPEN expression was studied in vitro by exposing the cartilage to IL-1 and subsequent activation of latent MMPs. Immune complex arthritis was characterized by an acute inflammation, with influx of mainly polymorphonuclear cells into the joint cavity. Expression of VDIPEN neoepitopes was consistently found in areas extensively depleted from proteoglycans. SLN-1KO mice did not show expression of the VDIPEN neoepitope, although inflammation and proteoglycan depletion was comparable to wild-type mice. In addition, erosions of cartilage were absent in SLN-1KO mice, but were present in wild-type mice, suggesting an important role for SLN-1 in cartilage destruction. In vitro studies showed that SLN-1 is also pivotally involved in IL-1-induced MMP activity. Stimulated polymorphonuclear neutrophils were able to activate latent MMPs present in the cartilage. Neutrophil elastase was also capable of activating IL-1-induced latent MMPs, which identifies elastase as a possible activator for latent VDIPEN-inducing MMPs. This study suggests that IC are important in the activation of latent MMPs in cartilage, possibly through polymorphonuclear neutrophil activation on the cartilage edge. SLN-1 is a pivotal enzyme in overall MMP-activity in cartilage during immune complex-mediated arthritis.Keywords
This publication has 34 references indexed in Scilit:
- Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.Journal of Clinical Investigation, 1996
- Adhesion and TNF Priming in Neutrophil-Mediated Cartilage DamageClinical Immunology and Immunopathology, 1996
- Degradation of cartilage aggrecan by collagenase‐3 (MMP‐13)FEBS Letters, 1996
- Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration.Journal of Clinical Investigation, 1995
- Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay.Journal of Clinical Investigation, 1994
- Cartilage degradation by polymorphonuclear leucocytes: in vitro assessment of the pathogenic mechanisms.Annals of the Rheumatic Diseases, 1993
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- The effects of estrogens on cartilage degradation usingin vivo andin vitro modelsInflammation Research, 1991
- Elastase secreted by activated polymorphonuclear leukocytes causes chondrocyte damage and matrix degradation in intact articular cartilageInflammation Research, 1988
- Interaction of polymorphonuclear leukocytes with immune complexes trapped in rheumatoid articular cartilageArthritis & Rheumatism, 1983